Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
6 | 151920015 | intron variant | T/C | snv | 0.15 |
|
Female Urogenital Diseases and Pregnancy Complications; Cardiovascular Diseases | 0.010 | 1.000 | 1 | 2008 | 2008 | |||||||||
|
1.000 | 0.040 | 6 | 151962343 | intron variant | A/C | snv | 0.76 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||||
|
0.925 | 0.080 | 6 | 151797989 | intron variant | T/C | snv | 1.6E-02 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||||
|
0.925 | 0.080 | 6 | 151797989 | intron variant | T/C | snv | 1.6E-02 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||||
|
0.882 | 0.160 | 6 | 151926017 | intron variant | A/G;T | snv |
|
Nervous System Diseases; Mental Disorders | 0.010 | 1.000 | 1 | 2014 | 2014 | ||||||||
|
0.882 | 0.160 | 6 | 151926017 | intron variant | A/G;T | snv |
|
Nutritional and Metabolic Diseases; Endocrine System Diseases | 0.010 | 1.000 | 1 | 2008 | 2008 | ||||||||
|
0.882 | 0.160 | 6 | 151926017 | intron variant | A/G;T | snv |
|
Nervous System Diseases; Mental Disorders | 0.010 | 1.000 | 1 | 2014 | 2014 | ||||||||
|
1.000 | 0.040 | 6 | 152059380 | intron variant | C/T | snv | 0.22 |
|
Pathological Conditions, Signs and Symptoms; Neoplasms | 0.010 | 1.000 | 1 | 2012 | 2012 | |||||||
|
1.000 | 0.040 | 6 | 152059380 | intron variant | C/T | snv | 0.22 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2012 | 2012 | |||||||
|
1.000 | 0.080 | 6 | 151974478 | intron variant | G/C | snv | 5.1E-02 |
|
Digestive System Diseases; Neoplasms | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||||
|
0.827 | 0.160 | 6 | 151666222 | intron variant | G/T | snv | 0.11 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.720 | 1.000 | 3 | 2011 | 2014 | |||||||
|
0.827 | 0.160 | 6 | 151666222 | intron variant | G/T | snv | 0.11 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.720 | 1.000 | 3 | 2011 | 2014 | |||||||
|
0.827 | 0.160 | 6 | 151666222 | intron variant | G/T | snv | 0.11 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.010 | 1.000 | 1 | 2011 | 2011 | |||||||
|
0.827 | 0.160 | 6 | 151666222 | intron variant | G/T | snv | 0.11 |
|
Digestive System Diseases; Neoplasms | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||||
|
0.827 | 0.160 | 6 | 151666222 | intron variant | G/T | snv | 0.11 |
|
Neoplasms; Skin and Connective Tissue Diseases; Endocrine System Diseases | 0.010 | 1.000 | 1 | 2011 | 2011 | |||||||
|
6 | 152101320 | 3 prime UTR variant | T/A | snv | 1.3E-02 |
|
0.700 | 1.000 | 1 | 2012 | 2012 | ||||||||||
|
6 | 152097101 | intron variant | C/A;T | snv |
|
0.700 | 1.000 | 1 | 2012 | 2012 | |||||||||||
|
6 | 152097101 | intron variant | C/A;T | snv |
|
0.700 | 1.000 | 1 | 2012 | 2012 | |||||||||||
|
6 | 152097101 | intron variant | C/A;T | snv |
|
0.700 | 1.000 | 1 | 2012 | 2012 | |||||||||||
|
6 | 152097101 | intron variant | C/A;T | snv |
|
0.700 | 1.000 | 1 | 2012 | 2012 | |||||||||||
|
6 | 152062578 | intron variant | C/T | snv |
|
0.700 | 1.000 | 1 | 2012 | 2012 | |||||||||||
|
6 | 152062578 | intron variant | C/T | snv |
|
0.700 | 1.000 | 1 | 2012 | 2012 | |||||||||||
|
6 | 152062578 | intron variant | C/T | snv |
|
0.700 | 1.000 | 1 | 2012 | 2012 | |||||||||||
|
6 | 152062578 | intron variant | C/T | snv |
|
0.700 | 1.000 | 1 | 2012 | 2012 | |||||||||||
|
6 | 152062578 | intron variant | C/T | snv |
|
0.700 | 1.000 | 1 | 2012 | 2012 |